RecruitingNCT06504927
Biomarker Discovery in Lung Cancer - Malaysia
Sponsor
University of Malaya
Enrollment
400 participants
Start Date
Jan 16, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to 1. Identify biomarkers and signatures to differentiate between high-risk and lung cancer patients. 2. Discover blood-based biomarkers that can be used as an adjunct test to imaging diagnosis to improve patient follow-up.
Eligibility
Min Age: 30 Years
Inclusion Criteria6
- Male or female subjects aged 30 and above.
- No previous history of any cancers.
- Able to provide X-ray and/or LDCT results.
- Have either COPD or pulmonary nodules measuring less than 11mm, or deemed not for biopsy by attending physician
- Willing to go back for a follow-up X-ray or LDCT scan in the next clinical follow up as per standard of care.
- Willing to provide up to 30mL of blood in month-0 (first visit) and up to 21mL in the next standard of care follow up visit (second visit).
Exclusion Criteria3
- Subject has received chemotherapy or radiotherapy for cancer treatment, and any other cancer-related treatment.
- Subject is pregnant or lactating (self-declaration).
- Subject is unwilling or unable to provide signed informed consent
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06504927
Related Trials
Virtual Agent Feasibility in Oncology Patients (NTT Data)
NCT066820131 location
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
NCT046786483 locations
Empathic Communication Skills (ECS) Training
NCT0545684112 locations
Study of Novel Treatment Combinations in Patients With Lung Cancer
NCT05633667100 locations
Mid-transverse Process Combined With Erector Spinae Block Versus Paravertebral Plane Block
NCT066185991 location